Adults with primary membranous nephropathy achieved higher complete remission rates with obinutuzumab than tacrolimus in the pivotal phase 3 MAJESTY trial.

Total submission of tumors ≤3 cm in size recommended for histologic analysis; additional guidance provided for larger tumors.

A trial tested an enhanced recovery after surgery (ERAS) protocol in patients who underwent ambulatory transurethral resection (TURBT) of bladder cancer.

Significantly more participants randomly assigned to remote telehealth services received genetic counseling or testing.

Source: Getty Images An American Urological Association (AUA) guideline update on vasectomy discusses minimally invasive surgery for permanent male contraception – plus potential reversal. The ...

(HealthDay News) — Adequate staffing tops the list of factors that can help hospitals reattract the registered nurse (RN) workforce, according to a research letter published online Feb. 9 in JAMA ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

The FDA has given the green light to beetroot red and has also sanctioned the use of spirulina extract. (HealthDay News) — ...

Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1. (HealthDay News) — Prostate-specific membrane antigen ...

AI-directed triage led to interventions linked with reduced likelihood of immediate hospitalizations among patients receiving maintenance hemodialysis. AI-driven machine learning models may identify ...

Atrasentan shows clinically meaningful effects on kidney function in IgA nephropathy patients, including those receiving SGLT2 inhibitors.

The FDA designated this a Class I Recall after 860 serious injuries and 7 deaths were reported related to falsely low glucose readings. Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and ...